LncRNA SNHG14 silencing inhibited non-small cell lung cancer progression via miR-34a/HMGB1 axis and promoted NSCLC cell cisplatin sensitivity 12. The gene discussed is HMGB1; the disease is non-small cell lung carcinoma.